Mode
Text Size
Log in / Sign up
N/A Completed N=112 Randomized Treatment

Covered Metallic Stents for First-Line Treatment of Benign Bile Duct Strictures

Common Bile Duct Stricture
Source: ClinicalTrials.gov NCT01221311 ↗
Enrolled (actual)
112
Serious AEs
20.5%
Results posted
May 2017
Primary outcomePrimary: Early Clinical Success — 50; 41 Participants

Summary

The current standard of care for benign bile duct strictures involves placement of multiple plastic stents under endoscopic and fluoroscopic guidance to progressively dilate or stretch it open. This approach necessitates multiple procedures which may extend over one year before the stricture is adequately dilated. The investigators propose a study comparing the standard approach of plastic stenting with the use of newer, fully coated metallic stents which are self-expandable, thereby permitting successful dilation of benign bile duct strictures with fewer procedures.

Outcome Measures

OutcomeResultp-value
PRIMARY
Early Clinical Success
50; 41

Eligibility Criteria

Inclusion Criteria

  • Bismuth Type I benign bile duct stricture
  • Objective signs/symptoms related to the stricture

Exclusion Criteria

  • Suspected malignant etiology for the stricture
  • Prior endotherapy within one year of presentation,except in the following two scenarios: 1) Early ( 1cm below the cystic duct insertion
  • Age 8cm in length
  • Life expectancy < 1 year
  • Concomitant nonanastomotic biliary strictures or biliary casts
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01221311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search